Patel Dinesh V Ph D (CIK 0001120477)

Latest company ownership

Shares held
519,543
Last filed at
Nov 24, 2025
Confidence Score
41.9
2025Q4
Confidence Score History
2017Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 25, 2025 Jul 28, 2025 Protagonist Therapeutics, Inc CEO Sell 20.0 -10,415 -1.96% ✗ $570.5K
Jul 21, 2025 Jul 23, 2025 Protagonist Therapeutics, Inc CEO Sell 37.5 -27,444 -4.91% ✗ $2.9M
Feb 19, 2025 Feb 20, 2025 Protagonist Therapeutics, Inc CEO Sell 45.0 -5,359 -0.98% ✗ $204.6K
Nov 25, 2024 Nov 27, 2024 Protagonist Therapeutics, Inc CEO Sell 17.5 -107,000 -7.76% ✗ $4.7M
Jun 7, 2024 Jun 11, 2024 Protagonist Therapeutics, Inc CEO Sell 27.5 -35,000 -6.36% ✓ $1.2M
Apr 1, 2024 Apr 2, 2024 Protagonist Therapeutics, Inc CEO Sell 35.0 -25,000 -4.35% ✓ $707.8K
Mar 1, 2024 Mar 1, 2024 Protagonist Therapeutics, Inc CEO Sell 35.0 -30,000 -4.96% ✓ $948.6K
Feb 26, 2024 Feb 28, 2024 Protagonist Therapeutics, Inc CEO Sell 40.0 -10,915 -1.77% ✗ $322.3K
Feb 15, 2024 Feb 20, 2024 Protagonist Therapeutics, Inc CEO Sell 45.0 -3,717 -0.60% ✗ $104.9K
Dec 13, 2023 Dec 15, 2023 Protagonist Therapeutics, Inc CEO Sell 20.0 -75,000 -12.31% ✓ $1.5M
Feb 22, 2023 Jun 2, 2023 Protagonist Therapeutics, Inc CEO Sell 67.5 +7,835 0.44% ✗ $317.1K
Feb 28, 2022 Mar 2, 2022 Protagonist Therapeutics, Inc CEO Sell 45.0 -4,648 -0.91% ✗ $112.9K
Dec 21, 2021 Dec 23, 2021 Protagonist Therapeutics, Inc CEO Sell 20.0 -15,000 -3.05% ✗ $482.2K
Jan 19, 2021 Jan 20, 2021 Protagonist Therapeutics, Inc CEO Sell 30.0 -24,846 -5.51% ✓ $611.1K
Dec 3, 2019 Dec 3, 2019 Protagonist Therapeutics, Inc CEO Buy 90.0 +30,000 7.90% ✗ $168.5K
Aug 6, 2019 Aug 8, 2019 Protagonist Therapeutics, Inc CEO Sell 42.5 -10,792 -2.80% ✗ $95.5K
Feb 28, 2019 Mar 4, 2019 Protagonist Therapeutics, Inc CEO Sell 86.3 +26,567 7.44% ✗ $17.5K
Feb 6, 2019 Feb 8, 2019 Protagonist Therapeutics, Inc CEO Sell 42.5 -10,909 -2.96% ✗ $84.4K
Dec 21, 2017 Dec 21, 2017 Protagonist Therapeutics, Inc CEO Sell 37.5 -8,210 -4.13% ✓ $160.6K
Dec 20, 2017 Dec 20, 2017 Protagonist Therapeutics, Inc CEO Sell 51.3 -1,790 -0.93% ✓ $35K